A Lower-Risk Way To Play This “High-Octane” Healthcare Trend
A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…
Biotech Investing
Separating Promising Biotechs From The Most Promising Biotechs
“Today, I’m stepping in with an easy-to-use tool to help you find only the most compelling biotech stocks,” announces the author of today’s article. And…
The Cutting-Edge World Of Proteomics – And What Investors Need To Know
There’s a new type of revolutionary science on the horizon: proteomics. But just what is proteomics – and what do healthcare investors need to know…
Should These 3 Biotech Stocks Be Excised From Your Portfolio?
When it comes to the three biotech stocks discussed in today’s article, all of which are down 45% or more from their 52-week highs, should…
With A Potential Blockbuster Alzheimer’s Drug, Is This Ten-Bagger Stock Still A Buy?
With a potential blockbuster drug in its pipeline that would also be the first new therapy for Alzheimer’s disease in decades, the stock featured in…
This Biotech’s Unique Approach To Drug Development Could Give It The Best Chance Of Beating The Market This Year
When it comes to the author of today’s article’s top biotech stock pick for 2021, an under-the-radar name, he explains that “Many of the reasons…
New Biotech Stocks To Watch – And More!
Companies involved in spectroscopy, bioelectronic medicine and telemedicine make up the three new biotech stocks to watch highlighted in today’s article, which also highlights new…
These 3 Biotechs Have Different Approaches To A COVID-19 Vaccine, But The Same Analyst Rating: ‘Buy’
An intranasal vaccine, an mRNA vaccine, and a T-cell activation vaccine: the three biotech companies discussed in today’s article are approaching the virus that causes…
Is The Stage Being Set For A Strong Biotech Rally?
Amid setbacks for various potential COVID-19 vaccines and treatments, election risk, strengthening M&A activity, and more, what’s the outlook for healthcare and biotech in the…
This Biotech Stock Has High Return Potential – And A Potential Bump In The Road
The biotech company highlighted in today’s article, specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer, is one that…